Clinical trial · Observational
Diagnostic Biomarkers Exploration of Breast Cancer From Serum and Urine
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this observational study is to find the diagnostic biomarkers in serum and urine from early breast cancer patients. The main questions it aims to answer are: * compare the different biomarkers in serum and urine from breast cancer patients, benign lesions and healthy population. * construct the best diagnostic model by machine learning to distinguish breast cancer and non-breast cancer patients. Participants, including breast and non-breast cancer patients will be asked to provides blood and urine during their diagnosis and treatment process without changing the original treatment. When necessary, specimens will be collected during the surgery，without affecting pathological diagnosis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasm Female | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Collect blood and urine，pathological specimens if necessary | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Breast cancer patients
- description
- No intervention. The patients who are diagnosed as breast cancer by postoperative pathological.
- interventionNames
- Diagnostic Test: Collect blood and urine，pathological specimens if necessary
- label
- Patients with benign breast lesions
- description
- No intervention. The patients who are diagnosed asbenign breast lesions by postoperative pathological.
- interventionNames
- Diagnostic Test: Collect blood and urine，pathological specimens if necessary
- label
- Healthy population
- description
- No intervention. The volunteers.
- interventionNames
- Diagnostic Test: Collect blood and urine，pathological specimens if necessary
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: 1. Signing the consent of informedness; 2. Patients with breast mass who need surgery after examination; 3. Cardiac ultrasound indicates that the blood score of the heart is within the normal range; 4. ECOG≤0-2 points; 5. Oversure function is acceptable. Exclusion Criteria: 1. Merge other malignant tumors such as gynecologic oncology; 2. After evaluation, the internal organs are not suitable.
References
Publications (0)
Data not yet available